________________________________________________________
____Explicit____
336..338
1,0,1,2,1,1,1,2,1
#### Text ####
or
##############
#### Features ####
Ot, Comm, Null, Null
390..425
1,1;1,2;1,3;1,4
#### Text ####
said Oncor President Stephen Turner
##############
or, Expansion.Alternative.Disjunctive
____Arg1____
314..335
1,0,1,2,1,1,1,2,0
#### Text ####
whether it has spread
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
339..388
1,0,1,2,1,1,1,2,2
#### Text ####
whether there is a recurrence following treatment
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Implicit____
443
2
#### Features ####
Wr, Comm, Null, Null
so, Contingency.Cause.Result
____Arg1____
210..388
1,0
#### Text ####
The B/T gene rearrangement test is more accurate than existing tests for diagnosing the type of cancer, whether it has spread or whether there is a recurrence following treatment
##############
#### Features ####
Ot, Comm, Null, Null
390..425
1,1;1,2;1,3;1,4
#### Text ####
said Oncor President Stephen Turner
##############
____Arg2____
443..581
2,1,1
#### Text ####
the test initially will be used in conjunction with biopsies and other tests, but eventually might become the benchmark for tumor analysis
##############
#### Features ####
Ot, Comm, Null, Null
427..442
2,0;2,1,0;2,2
#### Text ####
Mr. Turner said
##############
________________________________________________________
________________________________________________________
____EntRel____
583
3
____Arg1____
427..581
2
#### Text ####
Mr. Turner said the test initially will be used in conjunction with biopsies and other tests, but eventually might become the benchmark for tumor analysis
##############
____Arg2____
583..673
3
#### Text ####
Mr. Turner said the test will be shipped in 45 days to hospitals and clinical laboratories
##############
________________________________________________________
________________________________________________________
____Explicit____
842..849
4,1,1,1,1,2,2,2,0
#### Text ####
because
##############
#### Features ####
Ot, Comm, Null, Null
677..765
4,0;4,1,0;4,2
#### Text ####
Dr. Wyndham Wilson, a cancer treatment specialist at the National Cancer Institute, said
##############
because, Contingency.Cause.Reason
____Arg1____
810..841
4,1,1,1,1,1;4,1,1,1,1,2,0;4,1,1,1,1,2,1;4,1,1,1,1,2,2,0;4,1,1,1,1,2,2,1
#### Text ####
but isn't having a major impact
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
850..921
4,1,1,1,1,2,2,2,1
#### Text ####
it is only occasionally useful in choosing the most effective treatment
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Explicit____
923..926
5,0,0
#### Text ####
But
##############
#### Features ####
Ot, Comm, Null, Null
1042..1057
5,1;5,2;5,3;5,4
#### Text ####
Dr. Wilson said
##############
but, Comparison.Contrast.Juxtaposition
____Arg1____
842..921
4,1,1,1,1,2,2,2
#### Text ####
because it is only occasionally useful in choosing the most effective treatment
##############
#### Features ####
Ot, Comm, Null, Null
677..765
4,0;4,1,0;4,2
#### Text ####
Dr. Wyndham Wilson, a cancer treatment specialist at the National Cancer Institute, said
##############
____Arg2____
927..1040
5,0,1;5,0,2
#### Text ####
the test may prove to be more sensitive in determining whether a tumor has spread or returned following treatment
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Implicit____
1060
6
#### Features ####
Ot, Comm, Null, Null
1108..1115
6,0;6,2;6,3;6,4;6,5;6,6
#### Text ####
he said
##############
so, Contingency.Cause.Result
____Arg1____
766..1040
4,1,1;5,0
#### Text ####
the test is widely used in research centers but isn't having a major impact because it is only occasionally useful in choosing the most effective treatment.
But the test may prove to be more sensitive in determining whether a tumor has spread or returned following treatment
##############
#### Features ####
Ot, Comm, Null, Null
677..765;1042..1057
4,0;4,1,0;4,2;5,1;5,2;5,3;5,4
#### Text ####
Dr. Wyndham Wilson, a cancer treatment specialist at the National Cancer Institute, said Dr. Wilson said
##############
____Arg2____
1060..1105
6,1
#### Text ####
We don't know yet how useful it's going to be
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____EntRel____
1301
8
____Arg1____
1119..1299
7
#### Text ####
Oncor, a six-year-old developer of genetic medical tests, projects that the cancer test will help it to post its first-ever profit during the first quarter of 1990, Mr. Turner said
##############
____Arg2____
1301..1443
8
#### Text ####
The company will charge $35 for a test and projects about $2 million in revenue from the test during the first 12 months of marketing, he said
##############
________________________________________________________
